Research

Medical Sciences

Title :

Targeted next generation sequencing (NGS) for evaluating PI3/AKT/mTOR pathway as a potential therapeutic target for triple negative breast cancer

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

Triple negative breast cancer

Principal Investigator :

Dr. Amanjit Bal, Professor, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh

Timeline Start Year :

2017

Contact info :

Details

Total Budget (INR):

 63,32,600

Organizations involved

Implementing Agency :

Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh

Funding Agency :

Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India

Related Research

A cost-effective radiation treatment delivery system for low- and middle-income countries
A phase Iib openlabel randomized controlled trial to evaluate the efficacy & safety of Ivermectin in reducing viral loads in patients with hematological disorders who are admitted with Covid-19 infection (Ice study)
A randomized, double-blind, placebo and active controlled, multicenter, phase 3 study to access the efficacy and safety of Filgotinib administered for 52 weeks in combination with Methotrexate (MTX) to subjects with moderately to severely active rheumatoid arthritis, who have an inadequate response to methotrexate
Acute myeloid leukemia and the dynamics of relapse
Alternate test protocols to minimize number of tests